
Please note that any information that you supply is protected by our Privacy Policy. Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, Decision News Media does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.
Sabinsa Corporation is a manufacturer and supplier of high quality innovative standardized herbal extracts, phytonutrients, probiotics, enzymes, spice extracts, minerals, specialty and fine chemicals.
Since 1988, it has brought to market more than 100 standardized botanical extracts and funded several clinical studies so as to fulfill its mission of providing alternative and complementary natural products for human nutrition and well-being. Its worldwide operations have grown to employ 1000 plus people in ten manufacturing, R&D, and distribution facilities in the US, India, Japan, Europe, Australia, South East Asia and South Africa, and it cultivates nearly 40,000 acres each year to ensure sustainable supplies of its key botanical products.
All products intended for human consumption are certified Kosher, with many Halal-certified.
Intellectual Property
Sabinsa’s IP portfolio consists of over 50 issued US and International patents and 25 pending applications, as well as, numerous trademarked ingredients, including Bacopin®, BioPerine®, Boswellin®, Citrin®, Cosmoperine®, Curcumin C3 Complex®, DigeZyme®, Fabenol®, FenuFibers®, Fenusterols®, ForsLean®, Gugulipid®, Gymnema Sylvestre GS4®, LactoSpore®, LactoWise™, LeanGard®, Momordicin®, Picroliv®, Resvenox®, Saberry™, Salaretin®, Selenium SeLECT®, Silbinol®, and Venocin®.